Cargando…
The therapeutic response in Gorham’s syndrome to the beta-blocking agent propranolol is correlated to VEGF-A, but not to VEGF-C or FLT1 expression
BACKGROUND: Gorham’s syndrome is a rare illness of unknown etiology. It is characterized by a local proliferation of blood or lymphatic vessels that in bones leads to progressive resorption and destruction. The cause of the disease is not elucidated, and therapeutic options remain limited. CASE PRES...
Autores principales: | Baud, Jessica, Lomri, Abderrahim, Graber, Denis, Bikfalvi, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524023/ https://www.ncbi.nlm.nih.gov/pubmed/26238450 http://dx.doi.org/10.1186/s13104-015-1259-9 |
Ejemplares similares
-
DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4)
por: Quentmeier, Hilmar, et al.
Publicado: (2012) -
Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia
por: SHIBUYA, Masabumi
Publicado: (2011) -
VEGF and sFLT-1 in serum of PIH patients and effects on the foetus
por: Tang, Yanhong, et al.
Publicado: (2019) -
Comparison of oral propranolol, oral rifampicin, and intravitreal anti-VEGF in central serous chorioretinopathy
por: Sandeep, K, et al.
Publicado: (2023) -
Zebrafish ProVEGF-C Expression, Proteolytic Processing and Inhibitory Effect of Unprocessed ProVEGF-C during Fin Regeneration
por: Khatib, Abdel-Majid, et al.
Publicado: (2010)